Scientific Publications Database

Article Title: Alemtuzumab-treated patients with relapsing-remitting MS show low rates of conversion to secondary progressive MS: 6-year follow-up of CARE-MS I and II
Authors: Horakova, D.; Boster, A.; Bertolotto, A.; Freedman, M.; Goelz, S.; Firmino, I.; Cavalier, S.; Thangavelu, K.; Margolin, D. H.; Ziemssen, T.
Journal: MULTIPLE SCLEROSIS JOURNAL Volume 23
Date of Publication:2017
Abstract:
.